Scinovex
review Open AccessTop 1% cited

Rho GTPases in cancer cell biology

FEBS Letters · 2008 · Vol. 582(14) · pp. 2093–2101
Francisco M. De La VegaAnne J. Ridley

Abstract

Rho GTPases contribute to multiple cellular processes that could affect cancer progression, including cytoskeletal dynamics, cell cycle progression, transcriptional regulation, cell survival and vesicle trafficking. In vitro several Rho GTPases have oncogenic activity and/or can promote cancer cell invasion, and this correlates with increased expression and activity in a variety of cancers. Conversely, other family members appear to act as tumour suppressors and are deleted, mutated or downregulated in some cancers. Genetic models are starting to provide new information on how Rho GTPases affect cancer development and progression. Here, we discuss how Rho GTPases could contribute to different steps of cancer progression, including proliferation, survival, invasion and metastasis.

Protein Kinase Regulation and GTPase SignalingMicrotubule and mitosis dynamicsHippo pathway signaling and YAP/TAZGTPaseBiologyCell biologyCancer cellMetastasisTumor progressionCancerCellCancer researchGenetics

MeSH terms

AnimalsHumansNeoplasm InvasivenessNeoplasm MetastasisNeoplasmsrho GTP-Binding ProteinsMice
Citations
771
FWCI
18.76
field-weighted impact
References
91
Percentile
100%
vs. same field & year
Citations per year
References
Rho GTPases are over-expressed in human tumors
International Journal of Cancer · 1999 · 662 citations
Tumour-cell invasion and migration: diversity and escape mechanisms
Nature reviews. Cancer · 2003 · 3,197 citations
Cadherin switching
Journal of Cell Science · 2008 · 748 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.